Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Lisata Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 20 | 21 | +1 |
| Shares | 766.2K | 785.7K | +19.6K (+2.6%) |
| Value | $2.30M | $2.33M | +$38.7K (+1.7%) |
New holders (2)
Institutions that held Lisata Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 23,273 | $69.4K | 0.00% |
| SBI Securities Co., Ltd. | 540 | $1.61K | 0.00% |
Sold out (1)
Institutions that held Lisata Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Susquehanna International Group, LLP | 11,019 | $33.1K |